SMA-话题@MedSci

#SMA#

157篇内容 | 3289人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1388935, encodeId=ea6f1388935e7, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=2020 EAN丨聚焦脊髓性肌萎缩症（SMA）治疗期望，共同推进全球SMA诊疗发展, objectType=article, longId=195767, objectId=b7d8195e67f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7d8195e67f5, replyNumber=0, likeNumber=71, createdTime=2020-06-14, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7d8195e67f5, moduleTitle=2020 EAN丨聚焦脊髓性肌萎缩症（SMA）治疗期望，共同推进全球SMA诊疗发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7d8195e67f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388934, encodeId=44ed1388934d8, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=诺华的天价基因疗法Zolgensma，在欧洲获批治疗脊柱性肌肉萎缩症, objectType=article, longId=194459, objectId=50e81944593f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50e81944593f, replyNumber=0, likeNumber=50, createdTime=2020-05-22, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50e81944593f, moduleTitle=诺华的天价基因疗法Zolgensma，在欧洲获批治疗脊柱性肌肉萎缩症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50e81944593f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388933, encodeId=5c2a138893339, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=JAMA Intern Med：SMASH行动对山东省盐摄入及血液的影响, objectType=article, longId=193133, objectId=6dbf1931332a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dbf1931332a, replyNumber=0, likeNumber=59, createdTime=2020-04-30, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dbf1931332a, moduleTitle=JAMA Intern Med：SMASH行动对山东省盐摄入及血液的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dbf1931332a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388932, encodeId=a5f21388932ef, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Cells：Mesenchymal MACF1促进SMAD7核转位驱动骨的形成, objectType=article, longId=192941, objectId=973319294179, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=973319294179, replyNumber=0, likeNumber=82, createdTime=2020-04-26, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=973319294179, moduleTitle=Cells：Mesenchymal MACF1促进SMAD7核转位驱动骨的形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=973319294179)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388931, encodeId=41a11388931b8, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=J Nucl Med：177 Lu-PSMA-617在转移性去势抵抗性前列腺癌中的剂量测定, objectType=article, longId=192821, objectId=a90819282151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a90819282151, replyNumber=0, likeNumber=74, createdTime=2020-04-24, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a90819282151, moduleTitle=J Nucl Med：177 Lu-PSMA-617在转移性去势抵抗性前列腺癌中的剂量测定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a90819282151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388930, encodeId=2e501388930b3, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=葛均波院士团队完成国内首例一站式TAVR+PTSMA术, objectType=article, longId=192503, objectId=83241925033f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83241925033f, replyNumber=0, likeNumber=61, createdTime=2020-04-20, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83241925033f, moduleTitle=葛均波院士团队完成国内首例一站式TAVR+PTSMA术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83241925033f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388929, encodeId=2b2e13889292d, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Losmapimod治疗面肩胛肱型肌营养不良症的I期临床试验取得积极结果, objectType=article, longId=190847, objectId=dcd819084eb8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcd819084eb8, replyNumber=0, likeNumber=70, createdTime=2020-03-27, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcd819084eb8, moduleTitle=Losmapimod治疗面肩胛肱型肌营养不良症的I期临床试验取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcd819084eb8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388928, encodeId=4a941388928d5, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=5年随访数据证明Zolgensma基因疗法针对脊髓性肌萎缩症的安全性和有效性, objectType=article, longId=190825, objectId=4f7c19082592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f7c19082592, replyNumber=0, likeNumber=57, createdTime=2020-03-27, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f7c19082592, moduleTitle=5年随访数据证明Zolgensma基因疗法针对脊髓性肌萎缩症的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f7c19082592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388927, encodeId=9936138892eb7, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Cell Death Dis：抑制TGF-β/Smad3信号通路可阻断胰岛β细胞凋亡, objectType=article, longId=190701, objectId=c6f8190e017b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6f8190e017b, replyNumber=0, likeNumber=39, createdTime=2020-03-25, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6f8190e017b, moduleTitle=Cell Death Dis：抑制TGF-β/Smad3信号通路可阻断胰岛β细胞凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6f8190e017b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388926, encodeId=c5f9138892694, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=诺华的基因疗法Zolgensma，在日本获批治疗脊髓性肌萎缩症（SMA）儿童患者, objectType=article, longId=190503, objectId=eb4819050376, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb4819050376, replyNumber=0, likeNumber=67, createdTime=2020-03-22, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb4819050376, moduleTitle=诺华的基因疗法Zolgensma，在日本获批治疗脊髓性肌萎缩症（SMA）儿童患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb4819050376)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388925, encodeId=701b1388925cc, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Mol Med Rep：针灸通过TGF-β/ Smad通路减轻肾脏间质纤维化, objectType=article, longId=189209, objectId=7359189209b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7359189209b0, replyNumber=0, likeNumber=45, createdTime=2020-03-04, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7359189209b0, moduleTitle=Mol Med Rep：针灸通过TGF-β/ Smad通路减轻肾脏间质纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7359189209b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388924, encodeId=86fa13889243a, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Clinica Chimica Acta：2例中国Myhre综合征患者SMAD4致病变异？, objectType=article, longId=189106, objectId=786c189106fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=786c189106fe, replyNumber=0, likeNumber=70, createdTime=2020-03-03, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=786c189106fe, moduleTitle=Clinica Chimica Acta：2例中国Myhre综合征患者SMAD4致病变异？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=786c189106fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388923, encodeId=606a1388923e9, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=J Orthop Res：去氯雷他定通过抑制BMP2-Smad1 / 5/8信号传导抑制异位骨化, objectType=article, longId=188107, objectId=c85018810e7b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c85018810e7b, replyNumber=0, likeNumber=66, createdTime=2020-02-16, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c85018810e7b, moduleTitle=J Orthop Res：去氯雷他定通过抑制BMP2-Smad1 / 5/8信号传导抑制异位骨化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c85018810e7b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388922, encodeId=0bb9138892273, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=脊髓性肌萎缩症（SMA）：SMN2剪接修饰剂risdiplam显示出明显作用, objectType=article, longId=187658, objectId=7b6118e65800, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b6118e65800, replyNumber=0, likeNumber=72, createdTime=2020-02-09, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b6118e65800, moduleTitle=脊髓性肌萎缩症（SMA）：SMN2剪接修饰剂risdiplam显示出明显作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b6118e65800)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388921, encodeId=bde0138892142, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=FDA授予Losmapimod治疗面肩肱型肌营养不良症（FSHD）的孤儿药资格, objectType=article, longId=187019, objectId=768218e019fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=768218e019fc, replyNumber=0, likeNumber=68, createdTime=2020-02-01, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=768218e019fc, moduleTitle=FDA授予Losmapimod治疗面肩肱型肌营养不良症（FSHD）的孤儿药资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=768218e019fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388920, encodeId=5047138892084, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Regeneron的garetosmab显着降低了肌肉骨化症（"石头人症"）患者的骨骼异常增生, objectType=article, longId=186028, objectId=8a7a18602841, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a7a18602841, replyNumber=0, likeNumber=0, createdTime=2020-01-11, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a7a18602841, moduleTitle=Regeneron的garetosmab显着降低了肌肉骨化症（"石头人症"）患者的骨骼异常增生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a7a18602841)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388919, encodeId=9ae4138891994, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Prostate Cancer P D：18F-PSMA-1007 PET/CT在生化复发前列腺癌患者中的诊断表现研究, objectType=article, longId=184879, objectId=e1d41848e957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1d41848e957, replyNumber=0, likeNumber=63, createdTime=2019-12-19, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1d41848e957, moduleTitle=Prostate Cancer P D：18F-PSMA-1007 PET/CT在生化复发前列腺癌患者中的诊断表现研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1d41848e957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388918, encodeId=9d0f138891834, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=FDA暂时搁置了对鞘内施用SMA基因疗法Zolgensma的研究, objectType=article, longId=182191, objectId=2b0518219190, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0518219190, replyNumber=0, likeNumber=83, createdTime=2019-11-01, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0518219190, moduleTitle=FDA暂时搁置了对鞘内施用SMA基因疗法Zolgensma的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b0518219190)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388917, encodeId=227b138891e01, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=鞘内注射AVXS-101治疗2型SMA患者的STRONG试验取得阳性结果, objectType=article, longId=180634, objectId=8340180634bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8340180634bd, replyNumber=0, likeNumber=64, createdTime=2019-10-09, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8340180634bd, moduleTitle=鞘内注射AVXS-101治疗2型SMA患者的STRONG试验取得阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8340180634bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388916, encodeId=9066138891626, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=面肩肱型肌营养不良症（FSHD）：Losmapimod的I期临床试验取得积极结果, objectType=article, longId=180555, objectId=cca71805552c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cca71805552c, replyNumber=0, likeNumber=0, createdTime=2019-10-07, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cca71805552c, moduleTitle=面肩肱型肌营养不良症（FSHD）：Losmapimod的I期临床试验取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cca71805552c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SMA

2020-05-29

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

2020 EAN丨聚焦脊髓性肌萎缩症（SMA）治疗期望，共同推进全球SMA诊疗发展

2020-06-14

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

诺华的天价基因疗法Zolgensma，在欧洲获批治疗脊柱性肌肉萎缩症

2020-05-22

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

JAMA Intern Med：SMASH行动对山东省盐摄入及血液的影响

2020-04-30

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Cells：Mesenchymal MACF1促进SMAD7核转位驱动骨的形成

2020-04-26

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

J Nucl Med：177 Lu-PSMA-617在转移性去势抵抗性前列腺癌中的剂量测定

2020-04-24

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

葛均波院士团队完成国内首例一站式TAVR+PTSMA术

2020-04-20

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Losmapimod治疗面肩胛肱型肌营养不良症的I期临床试验取得积极结果

2020-03-27

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

5年随访数据证明Zolgensma基因疗法针对脊髓性肌萎缩症的安全性和有效性

2020-03-27

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Cell Death Dis：抑制TGF-β/Smad3信号通路可阻断胰岛β细胞凋亡

2020-03-25

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

诺华的基因疗法Zolgensma，在日本获批治疗脊髓性肌萎缩症（SMA）儿童患者

2020-03-22

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Mol Med Rep：针灸通过TGF-β/ Smad通路减轻肾脏间质纤维化

2020-03-04

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Clinica Chimica Acta：2例中国Myhre综合征患者SMAD4致病变异？

2020-03-03

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

J Orthop Res：去氯雷他定通过抑制BMP2-Smad1 / 5/8信号传导抑制异位骨化

2020-02-16

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

脊髓性肌萎缩症（SMA）：SMN2剪接修饰剂risdiplam显示出明显作用

2020-02-09

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

FDA授予Losmapimod治疗面肩肱型肌营养不良症（FSHD）的孤儿药资格

2020-02-01

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Regeneron的garetosmab显着降低了肌肉骨化症（"石头人症"）患者的骨骼异常增生

2020-01-11

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Prostate Cancer P D：18F-PSMA-1007 PET/CT在生化复发前列腺癌患者中的诊断表现研究

2019-12-19

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

FDA暂时搁置了对鞘内施用SMA基因疗法Zolgensma的研究

2019-11-01

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

鞘内注射AVXS-101治疗2型SMA患者的STRONG试验取得阳性结果

2019-10-09

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

面肩肱型肌营养不良症（FSHD）：Losmapimod的I期临床试验取得积极结果

2019-10-07

科室
- - 订阅+
  - 更多科室
工具
服务